It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.

Novo Nordisk said on Wednesday it plan to file its experimental next-generation obesity drug CagriSema for regulatory ...

Bushra Sumra’s career highlights the profound impact that expertise in clinical research and regulatory compliance can have ...

In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...

Navigating regulatory hurdles in the U.S. and Europe, plus fierce competition from rival Apellis, Astellas’ geographic ...

US-based immuno-dermatology company Alys Pharmaceuticals has received clearance from the US Food and Drug Administration (FDA ...

The Budget Estimates (BE) for the Centrally Sponsored Scheme of Strengthening of States Drug Regulatory System (SSDRS) for the fiscal year 2025-26 is Rs. 50 crore, around 33 per cent less than the ...

Over 400 enforcement actions, including show cause notices, production stoppages, and license cancellations, have been taken ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.